Aptahem appoints CMC Director
Aptahem (publ) announces today that Thomas Rupp has been appointed CMC Director in the company. Thomas has worked with Aptahem for several year in the role as aptamer expert, but he will now also take on the role as CMC Director. He has long and solid experience from working with aptamers and regulatory aspects, and he is considered one of the leading experts in the area in the world.In the role as CMC Director, Thomas Rupp is reponsible for the manufacturing of Apta-1 and the regulatory aspects of the manufacturing to ensure that Aptahem fulfills the regulations needed to start clinical